Search Within

Human Oncology and Pathogenesis Program

Formats
  1. Journal Article (3011)
  2. Meeting Abstract (2565)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (42)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (16)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. GSK Faculty (5763)
  2. Department of Medicine (4315)
  3. Department of Pathology and Laboratory Medicine (3068)
  4. Tow Center for Developmental Oncology (TCDO) (2637)
  5. Solid Tumor Oncology Division (2631)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2578)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Ross Levine (783)
  3. David Solit (781)
  4. Michael Berger (768)
  5. Nikolaus Schultz (491)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (165)
  2. 2024 (381)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (649)
  2. Blood (517)
  3. Cancer Research (412)
  4. Modern Pathology (300)
  5. Clinical Cancer Research (269)
  6. Laboratory Investigation (265)

More Publications

Publishers
  1. American Association for Cancer Research (874)
  2. Nature Publishing Group (766)
  3. American Society of Clinical Oncology (717)
  4. American Society of Hematology (564)
  5. Elsevier Inc. (420)
  6. Nature Research (313)

More Publishers

Results (5981)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Persaud, Y.; Sawai, A.; Grbovic-Huezo, O.; Janakiraman, M.; Rosen, N.; Solit, D. B.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • PHA-739358, an aurora kinase inhibitor, induces clinical responses in chronic myeloid leukemia harboring T315I mutations of BCR-ABL
    Meeting Abstract

    Paquette, R. L.; Shah, N. P.; Sawyers, C. L.; Martinelli, G.; John, N.; Chalukya, M.; Rocchetti, M.; Fiocchi, C.; Clomis, S.; Capolongo, L.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Comprehensive detection of gene fusions in sarcomas and other cancers using exon-level expression data obtained by affymetrix exon arrays
    Meeting Abstract

    Motoi, T.; Socci, N.; Lash, A.; Mertens, F.; Gerald, W.; Ladanyi, M.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Comprehensive detection of gene fusions in sarcomas and other cancers using exon-level expression data obtained by affymetrix exon arrays
    Meeting Abstract

    Motoi, T.; Socci, N.; Lash, A.; Mertens, F.; Gerald, W.; Ladanyi, M.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Tanespimycin (an Hsp90 inhibitor) and trastuzumab is an active combination in patients (pts) with Her2-positive trastuzumab-refractory metastatic breast cancer (MBC): Phase 2 trial
    Meeting Abstract

    Modi, S.; Stopeck, A.; Kinden, H.; Sugarman, S.; Ma, W.; Solit, D.; Kersey, K.; Johnson, R.; Hannah, A. L.; Hudis, C.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Biomarkers of brain tumors to EGFR-TKI
    Meeting Abstract

    Mellinghoff, I.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression
    Meeting Abstract

    Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Long-term efficacy of dasatinib in chronic-phase CML: Results from the phase I trial (CA180002)
    Meeting Abstract

    Cortes, J.; Sawyers, C. L.; Kantarjian, H. M.; Shah, N. P.; Paquette, R.; Paliwal, P.; Bleickardt, E.; Talpaz, M.
    Blood (2007)

    Fulltext@MSK | Save